Literature DB >> 26272875

Specificity of Incident Diagnostic Outcomes in Patients at Clinical High Risk for Psychosis.

Jadon R Webb1, Jean Addington2, Diana O Perkins3, Carrie E Bearden4, Kristin S Cadenhead5, Tyrone D Cannon6, Barbara A Cornblatt7, Robert K Heinssen8, Larry J Seidman9, Sarah I Tarbox10, Ming T Tsuang11, Elaine F Walker12, Thomas H McGlashan10, Scott W Woods13.   

Abstract

It is not well established whether the incident outcomes of the clinical high-risk (CHR) syndrome for psychosis are diagnostically specific for psychosis or whether CHR patients also are at elevated risk for a variety of nonpsychotic disorders. We collected 2 samples (NAPLS-1, PREDICT) that contained CHR patients and a control group who responded to CHR recruitment efforts but did not meet CHR criteria on interview (help-seeking comparison patients [HSC]). Incident diagnostic outcomes were defined as the occurrence of a SIPS-defined psychosis or a structured interview diagnosis from 1 of 3 nonpsychotic Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) groups (anxiety, bipolar, or nonbipolar mood disorder), when no diagnosis in that group was present at baseline. Logistic regression revealed that the CHR vs HSC effect did not vary significantly across study for any emergent diagnostic outcome; data from the 2 studies were therefore combined. CHR (n = 271) vs HSC (n = 171) emergent outcomes were: psychosis 19.6% vs 1.8%, bipolar disorders 1.1% vs 1.2%, nonbipolar mood disorders 4.4% vs 5.3%, and anxiety disorders 5.2% vs 5.3%. The main effect of CHR vs HSC was statistically significant (OR = 13.8, 95% CI 4.2-45.0, df = 1, P < .001) for emergent psychosis but not for any emergent nonpsychotic disorder. Sensitivity analyses confirmed these findings. Within the CHR group emergent psychosis was significantly more likely than each nonpsychotic DSM-IV emergent disorder, and within the HSC group emergent psychosis was significantly less likely than most emergent nonpsychotic disorders. The CHR syndrome is specific as a marker for research on predictors and mechanisms of developing psychosis.
© The Author 2015. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  anxiety disorder; bipolar disorder; nonbipolar mood disorder; validity

Mesh:

Year:  2015        PMID: 26272875      PMCID: PMC4535651          DOI: 10.1093/schbul/sbv091

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  72 in total

Review 1.  Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis.

Authors:  Diana O Perkins; Hongbin Gu; Kalina Boteva; Jeffrey A Lieberman
Journal:  Am J Psychiatry       Date:  2005-10       Impact factor: 18.112

2.  Duration of untreated prodromal symptoms and 12-month functional outcome of individuals at risk of psychosis.

Authors:  P Fusar-Poli; A Meneghelli; L Valmaggia; P Allen; F Galvan; P McGuire; A Cocchi
Journal:  Br J Psychiatry       Date:  2009-02       Impact factor: 9.319

3.  A clinical staging model for early intervention youth mental health services.

Authors:  Shane P M Cross; Daniel F Hermens; Elizabeth M Scott; Antonia Ottavio; Patrick D McGorry; Ian B Hickie
Journal:  Psychiatr Serv       Date:  2014-07       Impact factor: 3.084

Review 4.  The psychosis high-risk state: a comprehensive state-of-the-art review.

Authors:  Paolo Fusar-Poli; Stefan Borgwardt; Andreas Bechdolf; Jean Addington; Anita Riecher-Rössler; Frauke Schultze-Lutter; Matcheri Keshavan; Stephen Wood; Stephan Ruhrmann; Larry J Seidman; Lucia Valmaggia; Tyrone Cannon; Eva Velthorst; Lieuwe De Haan; Barbara Cornblatt; Ilaria Bonoldi; Max Birchwood; Thomas McGlashan; William Carpenter; Patrick McGorry; Joachim Klosterkötter; Philip McGuire; Alison Yung
Journal:  JAMA Psychiatry       Date:  2013-01       Impact factor: 21.596

5.  Comparison of relaxation training with a cognitive-behavioural intervention for indicated prevention of depression in university students: a randomized controlled trial.

Authors:  Fernando L Vázquez; Angela Torres; Vanessa Blanco; Olga Díaz; Patricia Otero; Elisabet Hermida
Journal:  J Psychiatr Res       Date:  2012-08-30       Impact factor: 4.791

6.  Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: prospective follow-up of 245 clinical high-risk outpatients in four countries.

Authors:  Raimo K R Salokangas; Stephan Ruhrmann; Heinrich Graf von Reventlow; Markus Heinimaa; Tanja Svirskis; Tiina From; Sinikka Luutonen; Georg Juckel; Don Linszen; Peter Dingemans; Max Birchwood; Paul Patterson; Frauke Schultze-Lutter; Joachim Klosterkötter
Journal:  Schizophr Res       Date:  2012-03-31       Impact factor: 4.939

7.  Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults.

Authors:  N Breslau; T Roth; L Rosenthal; P Andreski
Journal:  Biol Psychiatry       Date:  1996-03-15       Impact factor: 13.382

8.  Treatment history in the psychosis prodrome: characteristics of the North American Prodrome Longitudinal Study Cohort.

Authors:  Kristin S Cadenhead; Jean Addington; Tyrone Cannon; Barbara Cornblatt; Thomas McGlashan; Diana Perkins; Larry Seidman; Ming Tsuang; Elaine Walker; Scott Woods; Robert Heinssen
Journal:  Early Interv Psychiatry       Date:  2010-08       Impact factor: 2.732

9.  Physical activity and prevalence and incidence of mental disorders in adolescents and young adults.

Authors:  Andreas Ströhle; Michael Höfler; Hildegard Pfister; Anne-Grit Müller; Jürgen Hoyer; Hans-Ulrich Wittchen; Roselind Lieb
Journal:  Psychol Med       Date:  2007-06-20       Impact factor: 7.723

Review 10.  The concept of basic symptoms in schizophrenic and schizoaffective psychoses.

Authors:  G Huber; G Gross
Journal:  Recenti Prog Med       Date:  1989-12
View more
  29 in total

1.  Lack of evidence to favor specific preventive interventions in psychosis: a network meta-analysis.

Authors:  Cathy Davies; Andrea Cipriani; John P A Ioannidis; Joaquim Radua; Daniel Stahl; Umberto Provenzani; Philip McGuire; Paolo Fusar-Poli
Journal:  World Psychiatry       Date:  2018-06       Impact factor: 49.548

2.  Diagnostic Concepts in the Context of Clinical High Risk/Attenuated Psychosis Syndrome.

Authors:  William T Carpenter; Jason Schiffman
Journal:  Schizophr Bull       Date:  2015-07-10       Impact factor: 9.306

3.  Improving outcomes of first-episode psychosis: an overview.

Authors:  Paolo Fusar-Poli; Patrick D McGorry; John M Kane
Journal:  World Psychiatry       Date:  2017-10       Impact factor: 49.548

4.  The Early Psychosis Screener (EPS): Item development and qualitative validation.

Authors:  B B Brodey; J Addington; M B First; D O Perkins; S W Woods; E F Walker; B Walsh; J M Nieri; M B Nunn; J Putz; I S Brodey
Journal:  Schizophr Res       Date:  2017-12-16       Impact factor: 4.939

5.  Latent Profile Analysis and Conversion to Psychosis: Characterizing Subgroups to Enhance Risk Prediction.

Authors:  Kristin M Healey; David L Penn; Diana Perkins; Scott W Woods; Richard S E Keefe; Jean Addington
Journal:  Schizophr Bull       Date:  2018-02-15       Impact factor: 9.306

6.  Lack of Diagnostic Pluripotentiality in Patients at Clinical High Risk for Psychosis: Specificity of Comorbidity Persistence and Search for Pluripotential Subgroups.

Authors:  Scott W Woods; Albert R Powers; Jerome H Taylor; Charlie A Davidson; Jason K Johannesen; Jean Addington; Diana O Perkins; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Thomas H McGlashan
Journal:  Schizophr Bull       Date:  2018-02-15       Impact factor: 9.306

7.  Comorbid diagnoses for youth at clinical high risk of psychosis.

Authors:  Jean Addington; Danijela Piskulic; Lu Liu; Jonathan Lockwood; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Carrie E Bearden; Daniel H Mathalon; Scott W Woods
Journal:  Schizophr Res       Date:  2017-03-31       Impact factor: 4.939

8.  Real-World Clinical Outcomes Two Years After Transition to Psychosis in Individuals at Clinical High Risk: Electronic Health Record Cohort Study.

Authors:  Paolo Fusar-Poli; Andrea De Micheli; Rashmi Patel; Lorenzo Signorini; Syed Miah; Thomas Spencer; Philip McGuire
Journal:  Schizophr Bull       Date:  2020-04-18       Impact factor: 9.306

9.  Development and Validation of a Clinically Based Risk Calculator for the Transdiagnostic Prediction of Psychosis.

Authors:  Paolo Fusar-Poli; Grazia Rutigliano; Daniel Stahl; Cathy Davies; Ilaria Bonoldi; Thomas Reilly; Philip McGuire
Journal:  JAMA Psychiatry       Date:  2017-05-01       Impact factor: 21.596

10.  The Clinical High-Risk State for Psychosis (CHR-P), Version II.

Authors:  Paolo Fusar-Poli
Journal:  Schizophr Bull       Date:  2017-01       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.